FDA Drug Application (022287) for DEXILANT by TAKEDA PHARMS USA

Back to FDA Applications sponsored by TAKEDA PHARMS USA

Application Number022287
Product Number001
FormCAPSULE, DELAYED RELEASE;ORAL
Dosage30MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDEXILANT
Active IngredientDEXLANSOPRAZOLE

Active IngredientCount
List of drugs with Active Ingredient DEXLANSOPRAZOLE3


Back to FDA Applications sponsored by TAKEDA PHARMS USA